Reinforcement of cell-mediated immunity driven by tumor-associated epstein-barr virus (ebv)-specific t cells during targeted b-cell therapy with rituximab

HIGHLIGHTS

• who: Sabine Tischer-Zimmermann and collaborators from the Meharry Medical College, United States University of Washington, United States have published the article: Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab, in the Journal: (JOURNAL)
• what: COPYRIGHT Santamorena Mausberg Stoll Du00f6ring Kalinke Blasczyk Maecker-Kolhoff and This is an open-access article use distribution or reproduction in other forums is permitted provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.